Jacobs Levy Equity Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
+92,842
| New | +$204K | ﹤0.01% | 984 |
|
|
2025
Q1 | – | Sell |
-708,409
| Closed | -$900K | – | 1104 |
|
|
2024
Q4 | $900K | Buy |
708,409
+178,575
| +34% | +$227K | ﹤0.01% | 728 |
|
|
2024
Q3 | $1.81M | Buy |
529,834
+302,652
| +133% | +$1.03M | 0.01% | 624 |
|
|
2024
Q2 | $1.06M | Buy |
227,182
+108,042
| +91% | +$505K | ﹤0.01% | 727 |
|
|
2024
Q1 | $884K | Sell |
119,140
-165,688
| -58% | -$1.23M | ﹤0.01% | 736 |
|
|
2023
Q4 | $2.89M | Buy |
284,828
+201,732
| +243% | +$2.04M | 0.01% | 537 |
|
|
2023
Q3 | $648K | Buy |
83,096
+64,742
| +353% | +$505K | ﹤0.01% | 750 |
|
|
2023
Q2 | $151K | Buy |
+18,354
| New | +$151K | ﹤0.01% | 937 |
|
|
2023
Q1 | – | Sell |
-15,103
| Closed | -$134K | – | 991 |
|
|
2022
Q4 | $134K | Sell |
15,103
-92,035
| -86% | -$816K | ﹤0.01% | 921 |
|
|
2022
Q3 | $1.31M | Buy |
+107,138
| New | +$1.31M | 0.01% | 649 |
|
|
2022
Q2 | – | Sell |
-75,659
| Closed | -$1.44M | – | 1019 |
|
|
2022
Q1 | $1.44M | Buy |
+75,659
| New | +$1.44M | 0.01% | 693 |
|
|
2021
Q1 | – | Sell |
-69,345
| Closed | -$4.86M | – | 1046 |
|
|
2020
Q4 | $4.86M | Sell |
69,345
-20,675
| -23% | -$1.45M | 0.04% | 404 |
|
|
2020
Q3 | $2.53M | Sell |
90,020
-22,474
| -20% | -$631K | 0.03% | 474 |
|
|
2020
Q2 | $3.33M | Buy |
112,494
+45,023
| +67% | +$1.33M | 0.04% | 430 |
|
|
2020
Q1 | $1.34M | Buy |
67,471
+33,894
| +101% | +$672K | 0.02% | 560 |
|
|
2019
Q4 | $994K | Buy |
+33,577
| New | +$994K | 0.01% | 691 |
|